Vadastuximab Talirine (SGN-CD33A; 33A) Combined With Azacitidine or Decitabine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Clinical trial NCT02785900 · TERMINATED
Trial details
- NCT number
- NCT02785900
- Sponsor
- Seagen Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-01
- Primary completion
- 2017-10-03
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.